Title |
Hsa-miR-1246, hsa-miR-320a and hsa-miR-196b-5p inhibitors can reduce the cytotoxicity of Ebola virus glycoprotein in vitro
|
---|---|
Published in |
Science China Life Sciences, September 2014
|
DOI | 10.1007/s11427-014-4742-y |
Pubmed ID | |
Authors |
MiaoMiao Sheng, Ying Zhong, Yang Chen, JianChao Du, XiangWu Ju, Chen Zhao, GuiGen Zhang, LiFang Zhang, KangTai Liu, Ning Yang, Peng Xie, DangSheng Li, Michael Q. Zhang, ChengYu Jiang |
Abstract |
Ebola virus (EBOV) causes a highly lethal hemorrhagic fever syndrome in humans and has been associated with mortality rates of up to 91% in Zaire, the most lethal strain. Though the viral envelope glycoprotein (GP) mediates widespread inflammation and cellular damage, these changes have mainly focused on alterations at the protein level, the role of microRNAs (miRNAs) in the molecular pathogenesis underlying this lethal disease is not fully understood. Here, we report that the mi-RNAs hsa-miR-1246, hsa-miR-320a and hsa-miR-196b-5p were induced in human umbilical vein endothelial cells (HUVECs) following expression of EBOV GP. Among the proteins encoded by predicted targets of these miRNAs, the adhesion-related molecules tissue factor pathway inhibitor (TFPI), dystroglycan1 (DAG1) and the caspase 8 and FADD-like apoptosis regulator (CFLAR) were significantly downregulated in EBOV GP-expressing HUVECs. Moreover, inhibition of hsa-miR-1246, hsa-miR-320a and hsa-miR-196b-5p, or overexpression of TFPI, DAG1 and CFLAR rescued the cell viability that was induced by EBOV GP. Our results provide a novel molecular basis for EBOV pathogenesis and may contribute to the development of strategies to protect against future EBOV pandemics. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Thailand | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 2% |
Unknown | 58 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 10 | 17% |
Student > Ph. D. Student | 9 | 15% |
Researcher | 9 | 15% |
Student > Master | 8 | 14% |
Other | 5 | 8% |
Other | 14 | 24% |
Unknown | 4 | 7% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 21 | 36% |
Biochemistry, Genetics and Molecular Biology | 8 | 14% |
Medicine and Dentistry | 6 | 10% |
Nursing and Health Professions | 4 | 7% |
Immunology and Microbiology | 3 | 5% |
Other | 10 | 17% |
Unknown | 7 | 12% |